Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administrationIdiopathic CD4+ lymphocytopenia: natural history and prognostic factorsImmune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs.Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infectionImmunologic predictors of coronary artery calcium progression in a contemporary HIV cohort.Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).Effects of lymphocyte isolation and timing of processing on detection of CD127 expression on T cells in human immunodeficiency virus-infected patients.Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infectionQuantifying and predicting the effect of exogenous interleukin-7 on CD4+ T cells in HIV-1 infection.The effect of leflunomide on cycling and activation of T-cells in HIV-1-infected participants.Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels.Cytomegalovirus immune reconstitution inflammatory syndrome manifesting as acute appendicitis in an HIV-infected patientPomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patientsInduction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infectiond-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation.Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals.Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection.Can early therapy reduce inflammation?Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndromeTh1-driven immune reconstitution disease in Mycobacterium avium-infected mice.Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome.Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH.Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infectionNaïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesisImmunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm.Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activationPeptide library-based evaluation of T-cell receptor breadth detects defects in global and regulatory activation in human immunologic diseases.Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction.Plasma levels of soluble CD14 independently predict mortality in HIV infection.The effect of intermittent IL-2 therapy on CD4 T cells in the gut in HIV-1-infected patientsHIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy.Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or deathLack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartmentsCD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressorsDifferential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.
P50
Q21090481-E7AEEAA6-A824-4E33-B9CE-793C8CA8A12AQ24648099-7C370430-8CEC-4E14-8EC3-1F741A9FB519Q27687272-9ED6A075-5B29-48C6-9BB4-3B2D3ACEFEB4Q28481938-6B85491C-4CC2-44C9-9D10-7AD5CA35B355Q30593046-110E76E2-7E34-4F7A-9759-4AE379414C52Q33428328-9DF7439A-DD8D-44D8-94B7-C3B9D8123A37Q33593834-E8D98CB9-E8FB-4214-92D2-BCA7C3D319CEQ33628799-8E89EA86-392C-4178-9B44-E7233635147FQ33650035-0A4C3CB2-285D-47F3-80C9-E807C34F4257Q33651140-77477886-BC30-41F7-883B-A693EEE87225Q33697836-162178AA-CF64-45BF-8CA8-61BDE12AAFD3Q33755011-5A6D994C-C155-41A1-9BBC-EAE0A26FD64AQ33816582-DC441185-3FCC-46D6-8867-9B5541A99C93Q33840429-AE7F6478-F9FE-4FB2-9271-C9FF6A90C53DQ33895698-6F8E3A61-8414-4E7C-B73D-EEE441DBD4B0Q33907642-CACEC271-8EAD-4EC9-B17D-71025DAC90C8Q33941296-ADB94F89-4D4D-4967-928B-5F5AFA7FDDC0Q33977594-9ABD3710-5297-4267-9A00-786C53354981Q34059557-63D1E2CA-FABE-437D-9D34-1C02F78FC5A5Q34075692-78074D02-8D45-410D-A252-33763E439DFAQ34159822-FD900565-DA80-4604-805F-EADCB9774922Q34255648-A8644AE7-29F2-4D3A-8EC7-93AFC8CD3743Q34282914-BF696B5F-9C28-460D-9D01-18EF5F96063AQ34310523-E4FC7074-F9D6-4595-BA34-65C2F015EC7DQ34310880-D27CAB9D-D88D-4352-9778-DB716F571E66Q34374063-76C0B55D-C388-4F45-BB05-5B8E358502D3Q34396067-3C7E1917-31E0-4982-B42B-35CAB961ECA5Q34435083-F981C984-72A2-4DC9-BEC2-873087F94A7DQ34505245-F8B07C6E-C864-4A60-95AC-E48E8F42496EQ34608946-119FE810-5EA4-43E2-B161-42C31BBC1326Q34682171-A5A4A48D-E4D1-4472-B6CC-011025B143DBQ34699557-4199EB93-DD4F-40E0-82C5-A4872DD919A3Q34730629-90FBEC57-4081-4724-B1C3-4D0587733102Q34764002-3EF80EA9-3518-4928-9EDE-FACED3AB9278Q34777903-E0BE620A-E757-46EB-A307-E7E8E5C493AAQ34779568-009E21F1-A3CD-44FD-A33F-A8ADDFA8E12FQ34988273-AF5BA871-1792-48A1-B829-CB89186623A9Q35043695-ADC90A37-6CE7-4BF4-8AEC-608E6AE12004Q35076969-9BD8E524-0E75-42A3-8EAA-DC88240DEF3BQ35112218-2128AAEB-2056-4F2E-A38E-59E0C72E2C66
P50
description
Greek scientist and physician
@en
científica y médica griega
@es
hulumtuese
@sq
onderzoeker
@nl
ricercatrice
@it
հետազոտող
@hy
name
Irini Sereti
@ast
Irini Sereti
@en
Irini Sereti
@es
Irini Sereti
@nl
Irini Sereti
@sl
type
label
Irini Sereti
@ast
Irini Sereti
@en
Irini Sereti
@es
Irini Sereti
@nl
Irini Sereti
@sl
prefLabel
Irini Sereti
@ast
Irini Sereti
@en
Irini Sereti
@es
Irini Sereti
@nl
Irini Sereti
@sl
P214
P244
P106
P1153
6603616412
P21
P213
0000 0003 8069 4489
P214
P244
n2012186818
P31
P496
0000-0002-0076-0224
P734
P7859
lccn-n2012186818